HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NPA Internal Review Sparked Suit Against Board Members, Ongoing Changes

This article was originally published in The Tan Sheet

Executive Summary

A review launched after NPA's former CFO filed a wrongful termination complaint in November refuted the allegations, but has "also shown that there was some governance that needed to change," says Executive Director and CEO Daniel Fabricant.

You may also be interested in...



NPA's Former CFO Alleges Improper Expenses By Fabricant, Religious And Gender Harassment

CEO Daniel Fabricant and the NPA board's president say former CFO Brent Weickert's allegations in a complaint filed in California state court are baseless. Weickert, with NPA from 1997 until October, says he was dismissed after he stated his concerns to NPA's board and to Fabricant.

Fabricant Ends Eventful Service In FDA Supplement Regulation To Head NPA

Daniel Fabricant will be the CEO of NPA, and leave his post as director of FDA’s Division of Dietary Supplement Programs, the association announced April 8.

NPA Maintains Limits On Retailer Membership

A proposed change would have removed the requirement that retail members have stores and that 75% of their sales come from natural foods, supplements and related items. But NPA members approved five bylaw amendments to simplify the process of voting for board members.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108822

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel